Amgen trial to evaluate cardiovascular impact of anemia treatment in CKD patients with type 2 diabetes

被引：0
|
作者：
不详
机构：
来源：
DIALYSIS & TRANSPLANTATION | 2004年 / 33卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R318 [生物医学工程];
学科分类号：
0831 ;
摘要：
引用
收藏
页码：756 / 756
页数：1
相关论文
共 50 条
  • [1] Mitigating the Cardiovascular Risk of Anemia in Patients with Type 2 Diabetes and CKD: Does Darbepoetin Help? The TREAT Trial
    Christi Hayes
    Anis Alam
    Julie Black-Peart
    Samy I. McFarlane
    Current Diabetes Reports, 2010, 10 (2) : 87 - 89
  • [2] Prevalence of CKD in Patients with Type 2 Diabetes and Cardiovascular Disease
    Yang, J.
    Lu, R.
    Wang, Y.
    Ke, J.
    Huang, W.
    Lu, Q.
    Zhao, D.
    Liu, G.
    Gao, H.
    Hong, T.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2024, 209
  • [3] Hemoglobin Stability in Patients With Anemia, CKD, and Type 2 Diabetes: An Analysis of the TREAT (Trial to Reduce Cardiovascular Events With Aranesp Therapy) Placebo Arm
    Skali, Hicham
    Lin, Julie
    Pfeffer, Marc A.
    Chen, Chao-Yin
    Cooper, Mark E.
    McMurray, John J. V.
    Nissenson, Allen R.
    Remuzzi, Giuseppe
    Rossert, Jerome
    Parfrey, Patrick S.
    Scott-Douglas, Nairne W.
    Singh, Ajay K.
    Toto, Robert
    Uno, Hajime
    Ivanovich, Peter
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2013, 61 (02) : 238 - 246
  • [4] Cardiovascular and CKD-Related Healthcare Costs for Patients with Type 2 Diabetes and CKD
    Singh, Rakesh
    Song, Jinlin
    Faust, Elizabeth
    Du, Yuxian
    Kong, Sheldon X.
    Betts, Keith A.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 272 - 272
  • [5] Effects of Dapagliflozin on Anemia in Patients With CKD With or Without Type 2 Diabetes: A Pre-Specified Analysis of the DAPA-CKD Trial
    Heerspink, Hiddo J. L.
    Koshino, Akihiko
    Schechter, Meir
    Vart, Priya
    Jongs, Niels
    Chertow, Glenn
    Toto, Robert D.
    Rossing, Peter
    Correa-Rotter, Ricardo
    McMurray, John
    Langkilde, Anna Maria
    Wheeler, David C.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 43 - 43
  • [6] Randomized Trial of Pegmolesatide for the Treatment of Anemia in Patients With Nondialysis CKD
    Xie, Jianteng
    Yang, Aicheng
    Qiu, Hongyu
    Peng, Xiaomei
    Lu, Wanhong
    Huang, Xiangyang
    Chen, Qinkai
    Zhong, Aimin
    Tang, Shuifu
    Wang, Qin
    Li, Chuan
    He, Liangliang
    Jia, Xiaohong
    Ma, Anran
    Wang, Fan
    Yu, Xueqing
    KIDNEY INTERNATIONAL REPORTS, 2025, 10 (03): : 720 - 729
  • [7] Anemia, bilirubin, and cardiovascular autonomic neuropathy in patients with type 2 diabetes
    Chung, Jin Ook
    Park, Seon-Young
    Cho, Dong Hyeok
    Chung, Dong Jin
    Chung, Min Young
    MEDICINE, 2017, 96 (15)
  • [8] Finerenone for Patients With CKD and Type 2 Diabetes
    Slomski, Anita
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 325 (08): : 713 - 713
  • [9] A Randomized Controlled Trial to Evaluate the Efficacy of Roxadustat Dosing Regimens in Patients with CKD and Anemia on Dialysis
    Tu Yan
    Liu Bi-Cheng
    Huang Cuihua
    Yuchen Zhang
    Pan Shuting
    Niu Wei
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
  • [10] Association Between Cardiac Biomarkers and the Development of ESRD in Patients With Type 2 Diabetes Mellitus, Anemia, and CKD
    Desai, Akshay S.
    Toto, Robert
    Jarolim, Petr
    Uno, Hajime
    Eckardt, Kai-Uwe
    Kewalramani, Reshma
    Levey, Andrew S.
    Lewis, Eldrin F.
    McMurray, John J. V.
    Parving, Hans-Henrik
    Solomon, Scott D.
    Pfeffer, Marc A.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2011, 58 (05) : 717 - 728
12345